These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36479564)

  • 1. Effect of Danhong injection on prognosis and inflammatory factor expression in patients with acute coronary syndrome during the perioperative period of percutaneous coronary intervention: A systematic review and meta-analysis.
    Li Y; Li D; Wang W; Li X; Li P; Zhang Y; Lin Q; Li Y
    Front Cardiovasc Med; 2022; 9():1029387. PubMed ID: 36479564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Efficacy of Danhong Injections at Different Time-points During the Perioperative Period of Acute Myocardial Infarction: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    He QY; Yu XY; Xiao Z; Sun X; Zhu WF; Yi XQ; Chen Q; Zhang JH; Chen SX; Zhou X; Nie HY; Shang HC; Chen XF
    Front Pharmacol; 2021; 12():643446. PubMed ID: 33995051
    [No Abstract]   [Full Text] [Related]  

  • 3. The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.
    Zou JB; Zhang XF; Wang J; Wang F; Cheng JX; Yang FY; Song X; Wang Y; Liang YL; Shi YJ
    Front Pharmacol; 2018; 9():550. PubMed ID: 29915535
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of danhong injection on ET-1, sP-sel, and hs-CRP in patients with acute coronary syndrome undergoing percutaneous coronary intervention].
    Zhao PX; Jiang S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jan; 31(1):11-4. PubMed ID: 21434335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials.
    Kan Z; Yan W; Yang M; Gao H; Meng D; Wang N; Fang Y; Wu L; Song Y
    Front Pharmacol; 2023; 14():1144419. PubMed ID: 36959861
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of Danhong injection for treating myocardial infarction: a systematic review and meta-analysis of randomized controlled trials.
    Yang S; Wang Y; Shen H; Chen T; Du H
    Front Pharmacol; 2024; 15():1371959. PubMed ID: 38939841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of danhong injection on platelet activation and inflammatory factors in patients of acute coronary syndrome after intervention therapy].
    Chen ZQ; Hong L; Wang H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Aug; 29(8):692-4. PubMed ID: 19848198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.
    Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
    PLoS One; 2017; 12(2):e0171682. PubMed ID: 28231287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
    Wei J; Liu S; Wang X; Li B; Qiao L; Wang Y; Zhu M
    Evid Based Complement Alternat Med; 2021; 2021():2672516. PubMed ID: 34931125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Network Meta-analysis of efficacy and safety of different traditional Chinese medicine injections in treating post-acute myocardial infarction heart failure].
    Sun Y; Qiao LJ; Wei JJ; Li B; Gao Y; Zhu MJ
    Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(21):5932-5945. PubMed ID: 38114189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meta-analysis of effect of Qishen Yiqi Dripping Pills combined with Western medicine on adverse cardiovascular events and quality of life after percutaneous coronary intervention].
    Dai QQ; Shi ZF; Hu JY; Han SJ; Zhong CM; Guan MK; Tian GH; Shang HC
    Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(6):1498-1510. PubMed ID: 33787149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Danhong Injection Combined with Naoxintong Tablets on Prognosis and Inflammatory Factor Expression in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.
    Lv Y; Pan Y; Gao Y; Lu J; Li Y; Bai J; Zhai J
    Acta Cardiol Sin; 2015 Jul; 31(4):301-7. PubMed ID: 27122886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials.
    Liu Y; Su Q; Li L
    Clin Cardiol; 2013 Dec; 36(12):E41-8. PubMed ID: 24038054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of Danhong injection on endothelial function and inflammatory factors after the percutaneous coronary intervention for coronary heart disease: A protocol of systematic review and meta-analysis of randomized controlled trials.
    Li S; Duan S; Ning Y; Zhang H; Zheng Q
    Medicine (Baltimore); 2020 Jul; 99(27):e20783. PubMed ID: 32629660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Danhong Injection (a Traditional Chinese Patent Medicine) for Acute Myocardial Infarction: A Systematic Review and Meta-Analysis.
    Liao P; Wang L; Guo L; Zeng R; Huang J; Zhang M
    Evid Based Complement Alternat Med; 2015; 2015():646530. PubMed ID: 26451156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Danhong injection in the treatment of acute coronary syndrome: a systematic review and meta-analysis.
    Wu JR; Zhang XM; Zhang B
    Am J Chin Med; 2015; 43(2):199-214. PubMed ID: 25787298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombomodulin can predict the incidence of second events in patients with acute coronary syndrome: Single-center, retrospective cohort study.
    Kosaki R; Minoura Y; Ogura K; Oishi Y; Tanaka L; Arai K; Nomura K; Sakai K; Sekimoto T; Nisikura T; Tsujita H; Kondo S; Tsukamoto S; Hamazaki Y; Kobayashi Y
    J Cardiol; 2018 Dec; 72(6):494-500. PubMed ID: 29887328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive Effect and Safety of Chinese Herbal Medicine in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Zheng S; Ma X; Kong Z; Yang C
    Altern Ther Health Med; 2024 May; 30(5):155-161. PubMed ID: 37917887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction.
    Wang JL; Guo CY; Li HW; Zhao XQ; Zhao SM
    Am J Med Sci; 2022 Apr; 363(4):333-341. PubMed ID: 34986361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Shi Z; Zhao C; Hu J; Dai Q; Guan M; Zhong C; Tian G; Shang H
    Evid Based Complement Alternat Med; 2020; 2020():3834128. PubMed ID: 32508947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.